Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of SSS67 in Healthy Adult Participants Via Single Intravenous Infusion

NCT07487545 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: SSS67 Injection
DRUG: Placebo

Sponsor

Shenyang Sunshine Pharmaceutical Co., LTD.